In this study we sought to correlate androgen receptor (AR) expression with tumor progression and disease-free survival (DFS) in breast cancer patients. We investigated AR expression in 450 breast cancer patients. We found that breast cancers expressing the estrogen receptor (ER) are more likely to co-express AR compared to ER-negative cancers (56.0
作者:He-Sheng, Jiang;Xia-Ying, Kuang;Wei-Li, Sun;Yan, Xu;Yi-Zi, Zheng;Yi-Rong, Liu;Guan-Tian, Lang;Feng, Qiao;Xin, Hu;Zhi-Ming, Shao
来源:Oncotarget 2016 年 7卷 27期